Life in 3D - Gelomics Newsletter August 2024
?? Welcome to our August newsletter! ??
This month, we’re thrilled to share that Gelomics has been named the 2024 KPMG High Growth Ventures Tech Innovator in Australia and will proudly represent the country at the global final in Lisbon this November. In addition, we’re honored to be finalists in the International Health category of the Premier of Queensland's Export Awards 2024. This month, we also spotlight groundbreaking research using our LunaGel? systems, celebrate our LunaCrosslinker? giveaway winner, and highlight the latest 3D cell culture advancements. Dive in for all the details and stay inspired!
It’s an honour to be selected from among such a strong group of finalists and to represent Australia at the KPMG Global Tech Innovator final at the Web Summit in Lisbon this November. We’re excited about the opportunity to showcase our technology on the global stage and to continue pushing the boundaries of what’s possible in biotech.
Read more about the announcement in Startup Daily’s article here.
This recognition as a finalist is a testament to our team's hard work and commitment to excellence in the international health sector. We are incredibly proud to be celebrated alongside other outstanding finalists who are pushing the boundaries of what is possible in exporting.
Watch our Export Awards finalist spotlight here.
Study cancer progression and EMT in a powerful in vitro format
Breast cancer cell invasiveness increases with ECM stiffness
Images show MDA-MB-231 spheroids cultured with LunaGel? Bovine Gelatin Low Stiffness ECMs with compressive moduli of (A) 1.5 kPA (healthy breast tissue), (B) 3.0 kPa (early breast cancer), and (C) 6 kPa (late-stage cancer). Cells display far more evidence of invasive and epithelial-mesenchymal transition (EMT) behaviours in stiffer matrices that resemble late-stage breast cancer - highlighting the power and importance of controlling matrix stiffness in in vitro models. Cells/spheroids were stained for cell nuclei (blue), β1-integrin (green), cell membrane (orange), and actin (magenta).
?? The winner of our LunaCrosslinker? giveaway is... ??
Empower Your Research with a LunaGel? 3D Tissue Culture System!
Congratulations to Biotech - Center for Biomedical Technologies at the University of Trento in Italy! We're pleased to be able to support your ground-breaking work in novel biomaterials.
Thank you to all who entered, and don't forget that you still have the opportunity to request a free demo of our LunaGel? 3D Tissue Culture ECM System!
领英推荐
Request a free demo at: https://www.gelomics.com/book-demo
The Latest 3D Cell Culture Papers
A recent Nature article explores the increasing shift away from animal models in scientific research, driven by advancements in human-tissue-based methods.
The paper argues that while animal research has traditionally been the cornerstone of biomedical research, it is not always the most effective or ethical approach. The authors advocate for the exploration and adoption of alternative methods, such as in vitro models, computational simulations, and 3D cell cultures, which can provide more accurate, cost-effective, and humane research outcomes. The paper emphasizes the importance of reducing reliance on animal models and highlights the potential of these alternatives to transform research practices.
This paper emphasizes the need for advanced co-culture models that integrate the enteric nervous system (ENS) with intestinal organoids to better mimic the physiological environment of the gastrointestinal (GI) tract. This approach aims to improve the study of GI diseases, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), and enhance drug testing and personalized medicine. The paper advocates for the further development and adoption of these models to revolutionize GI disease research and treatment.
View Whitepaper: LunaGel? Ultrapure GelMA Photocrosslinkable Extracellular Matrix
Gelomics Pty Ltd
60 Musk Avenue
Kelvin Grove, QLD 4059, Australia
t: 1800 865 060